EXANE DERIVATIVES: HQY position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on HQY, newest first. How the timeline and the estimate are built.
EXANE DERIVATIVES held 0 HQY shares at 2021-09-30 per its 13F-HR filed 2021-10-26.
the latest 13F is the newest step
- period ended2021-09-3013F 0 sharesChange vs previous 13F -782 shares
13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2021-06-3013F 782 sharesChange vs previous 13F +778 shares
0.01% of the 13F portfolio, value $61,215.
13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2021-03-3113F 4 sharesChange vs previous 13F -65 shares
<0.01% of the 13F portfolio, value $272.
13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2020-12-3113F 69 sharesChange vs previous 13F -830 shares
<0.01% of the 13F portfolio, value $4,810.
13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2020-09-3013F/A 899 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $46,181.
13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).